BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12235123)

  • 1. DEDD regulates degradation of intermediate filaments during apoptosis.
    Lee JC; Schickling O; Stegh AH; Oshima RG; Dinsdale D; Cohen GM; Peter ME
    J Cell Biol; 2002 Sep; 158(6):1051-66. PubMed ID: 12235123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DEDD association with cytokeratin filaments correlates with sensitivity to apoptosis.
    Schutte B; Henfling M; Ramaekers FC
    Apoptosis; 2006 Sep; 11(9):1561-72. PubMed ID: 16820959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switch in Fas-activated death signaling pathway as result of keratin 8/18-intermediate filament loss.
    Gilbert S; Ruel A; Loranger A; Marceau N
    Apoptosis; 2008 Dec; 13(12):1479-93. PubMed ID: 19002587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
    Sylvester PW; Shah S
    Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Keratin attenuates tumor necrosis factor-induced cytotoxicity through association with TRADD.
    Inada H; Izawa I; Nishizawa M; Fujita E; Kiyono T; Takahashi T; Momoi T; Inagaki M
    J Cell Biol; 2001 Oct; 155(3):415-26. PubMed ID: 11684708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
    Hotta T; Suzuki H; Nagai S; Yamamoto K; Imakiire A; Takada E; Itoh M; Mizuguchi J
    J Orthop Res; 2003 Sep; 21(5):949-57. PubMed ID: 12919886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis.
    Byun Y; Chen F; Chang R; Trivedi M; Green KJ; Cryns VL
    Cell Death Differ; 2001 May; 8(5):443-50. PubMed ID: 11423904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
    Izeradjene K; Douglas L; Delaney A; Houghton JA
    Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusing DEDD with ubiquitin changes its intracellular localization and apoptotic potential.
    Lee JC; Wang GX; Schickling O; Peter ME
    Apoptosis; 2005 Dec; 10(6):1483-95. PubMed ID: 16235027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermediate filaments control the intracellular distribution of caspases during apoptosis.
    Dinsdale D; Lee JC; Dewson G; Cohen GM; Peter ME
    Am J Pathol; 2004 Feb; 164(2):395-407. PubMed ID: 14742246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining characteristics of Types I and II apoptotic cells in response to TRAIL.
    Ozören N; El-Deiry WS
    Neoplasia; 2002; 4(6):551-7. PubMed ID: 12407450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DEDD and DEDD2 associate with caspase-8/10 and signal cell death.
    Alcivar A; Hu S; Tang J; Yang X
    Oncogene; 2003 Jan; 22(2):291-7. PubMed ID: 12527898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ARK5 suppresses the cell death induced by nutrient starvation and death receptors via inhibition of caspase 8 activation, but not by chemotherapeutic agents or UV irradiation.
    Suzuki A; Kusakai G; Kishimoto A; Lu J; Ogura T; Esumi H
    Oncogene; 2003 Sep; 22(40):6177-82. PubMed ID: 13679856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria.
    Zhang XD; Borrow JM; Zhang XY; Nguyen T; Hersey P
    Oncogene; 2003 May; 22(19):2869-81. PubMed ID: 12771938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death.
    Lawrence CP; Chow SC
    FEBS Lett; 2005 Nov; 579(28):6465-72. PubMed ID: 16289096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cells.
    Lane D; Cartier A; L'Espérance S; Côté M; Rancourt C; Piché A
    Gynecol Oncol; 2004 Jun; 93(3):594-604. PubMed ID: 15196850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. eIF3k regulates apoptosis in epithelial cells by releasing caspase 3 from keratin-containing inclusions.
    Lin YM; Chen YR; Lin JR; Wang WJ; Inoko A; Inagaki M; Wu YC; Chen RH
    J Cell Sci; 2008 Jul; 121(Pt 14):2382-93. PubMed ID: 18577580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
    Herr I; Ucur E; Herzer K; Okouoyo S; Ridder R; Krammer PH; von Knebel Doeberitz M; Debatin KM
    Cancer Res; 2003 Jun; 63(12):3112-20. PubMed ID: 12810637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IG20 (MADD splice variant-5), a proapoptotic protein, interacts with DR4/DR5 and enhances TRAIL-induced apoptosis by increasing recruitment of FADD and caspase-8 to the DISC.
    Ramaswamy M; Efimova EV; Martinez O; Mulherkar NU; Singh SP; Prabhakar BS
    Oncogene; 2004 Aug; 23(36):6083-94. PubMed ID: 15208670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines.
    Izeradjene K; Douglas L; Tillman DM; Delaney AB; Houghton JA
    Cancer Res; 2005 Aug; 65(16):7436-45. PubMed ID: 16103097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.